Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit Review0321 has been discontinued.
View all Non-selective Ionotropic Glutamate products.Broad spectrum EAA ligand.
S-enantiomer and R-enantiomer also available.
M. Wt | 195.17 |
Formula | C9H9NO4 |
Storage | Store at RT |
Purity | ≥99% (HPLC) |
CAS Number | 7292-81-1 |
PubChem ID | 5115 |
InChI Key | VTMJKPGFERYGJF-UHFFFAOYSA-N |
Smiles | NC(C(O)=O)C1=CC=C(C(O)=O)C=C1 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
References are publications that support the biological activity of the product.
Keywords: (RS)-4-Carboxyphenylglycine, (RS)-4-Carboxyphenylglycine supplier, Broad, spectrum, EAA, ligand, Glutamate, Ionotropic, Non-Selective, iGluR, Receptors, mGlur, Metabotropic, (RS)-4CPG, Non-selective, mGlu, 0321, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for (RS)-4-Carboxyphenylglycine include:
Singh et al (2006) Altered balance of glutamatergic/GABAergic synaptic input and associated changes in dendrite morphology after BDNF expression in BDNF-deficient hippocampal neurons. Addict Biol 26 7189 PMID: 16822976
Yokoi et al (1995) Refinement of odor molecule tuning by dendrodendritic synaptic inhibition in the olfactory bulb. J Neurosci 92 3371 PMID: 7724568
There are currently no reviews for this product. Be the first to review (RS)-4-Carboxyphenylglycine and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.